Read More

高雅光学认购目标公司经扩大后已发行的五成股本以投资中国烟台液化天然气项目

HONG KONG, Aug 10, 2021 - (亚太商讯 via SEAPRWire.com) - 高雅光学国际集团有限公司欣然宣布翠源环球有限公司(认购方)与喜上天然气码头控股有限公司(目标公司)及现有股东订立协议(该协议),据此,认购方已有条件同意认购,而目标公司已有条件同意发行及配发10,000新股,相当于目标公司经扩大后的已发行股本的50%,认购价为人民币2.23亿元,交易将以现金结算。认购事项将于该协议所有先决条件均已达成或获豁免后的第30个营业日(或该协议各方可能协议的其他日期)完成。直至该协议完成后,本公司将间接拥有50%目标公司股权,相当于烟台液化天然气项目公司约10.5%的等值权益(基于目标公司拥有烟台液化天然气项目公司21.0%的等值权益)。本集团董事对烟台液化天然气项目前景乐观,管理层预期此项目一年收入约人民币25亿元。烟台液化天然气项目已列为国家和山东省2021年重点项目,亦将成为全国第23个天然气接收站。直至现在,全国共有22个天然气接收站,其中15个由国有企业所拥有及运作。董事认为是次认购与本集团的投资策略一致,将使本集团收入来源及投资组合多元化。此外,本集团计划发展以天然气领域的产、供、储、销全产业链为目标,进一步提升本公司在液化天然气国际贸易的基础。媒介查询: New Smile Strategic IR & PR Consultancy 电话: +852 2126 7076Jenny Lai jenny.lai@newsmilehk.comJenny Cheung jenny.cheung@newsmilehk.com编辑垂注:本公司的资料高雅光学国际集团有限公司主要从事眼镜架及太阳眼镜之制造及买卖、物业投资、债务及证券投资、电影投资及发行以及能源业务。本集团是指本公司及其附属公司。现有股东及目标集团的数据现有股东郑芳,为中国居民及商人。目标公司是喜上天然气码头控股有限公司,为一间于英属处女群岛注册成立的投资控股有限公司,于该协议日期由现有股东全资拥有。认购方的资料翠源环球有限公司,为一间于英属处女群岛注册成立的有限公司,是本公司间接全资拥有的附属公司。烟台液化天然气项目公司的数据烟台液化天然气项目公司主要从事燃气经营、货物和技术进出口以及进出口代理服务,为一间执行烟台液化天然气项目而成立的项目公司。烟台液化天然气项目的数据旨在投资建设山东烟台港液化天然气接收站。预期烟台液化天然气项目将于2023年开始营运,营运期可达25年。中国国家发展和改革委员会已于2020年1月正式审批烟台液化天然气项目,目前该项目正于港口建设阶段。 Copyright 2021 亚太商讯. All rights reserved. (via SEAPRWire)

Read More

Elegance Optical subscribes 50% of the enlarged issued share capital of the Target Company for China’s Yantai Liquefied Natural Gas (LNG) Terminal Project investment

HONG KONG, Aug 10, 2021 - (ACN Newswire via SEAPRWire.com) - Elegance Optical International Holdings Limited ("The Company") is pleased to announce that Green Source Global Limited ("the Subscriber"), an indirect wholly-owned subsidiary of the Company, has entered into the agreement with H. Sterling LNG Terminal Holding Limited ("Target Company") and the Existing Shareholder ("Existing Shareholder"), pursuant to which the Subscriber has conditionally agreed to subscribe for, and the Target Company has conditionally agreed to issue and allot, 10,000 subscription shares, representing 50% of the issued share capital of the Target Company as enlarged at the subscription price of RMB223 million, to be settled in cash ("the Agreement").Completion of the subscription shall take place on the 30th business day after all the conditions precedent under the Agreement having been fulfilled or waived (or such other date as the parties to the Agreement may agree). Upon the completion, the Company will indirectly own 50% equity interest of the Target Company, representing approximately 10.5% equivalent interest in Yantai LNG Terminal Project Company of which 21.0% equivalent interests is held by t...

Read More

GF Securities Fully Support the Innovation and Entrepreneurship of Hong Kong Youths, Sponsored HKUST Entrepreneurship Competition for 5 Years

HONG KONG, Aug 10, 2021 - (ACN Newswire via SEAPRWire.com) - The HKUST-Sino One-Million-Dollar Entrepreneurship 2021 sponsored by GF Securities Co., Ltd. ("GF Securities", stock code: 1776.HK; 000776.SZ) for 5 consecutive years was successfully held recently. After fierce competition, the winner of the competition was granted to The Able Company, which collects surplus and unused bread from Hong Kong bakeries and restaurants and turns them into local craft beer, and the "GF Innovation Award" sponsored by GF Securities was granted to Solid-X Limited, which focuses on the development of next-generation solid-state batteries.Mr. Shen Minggao, the General Manager of GF Holdings (Hong Kong) Co., Ltd., a Hong Kong subsidiary of GF Securities, said, "This is the fifth year that GF Securities has participated in the competition. As a global investment bank rooted in the Greater Bay Area, GF Securities is committed to making full use of domestic and overseas capital markets to provide assistance to outstanding companies at different stages of development, we will also continue to fully support outstanding entrepreneurs, promote the development of start-ups, and help more young people realiz...

Read More

Apollomics, Inc. Doses First Patient in Phase I Clinical Trial of APL-102

Foster City, CA, Hangzhou and Shanghai, China, Aug 10, 2021 - (ACN Newswire via SEAPRWire.com) - Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination oncology therapies, today announced the successful dosing of the first patient in a Phase I clinical study of APL-102 in patients with advanced solid tumors. The Phase I trial is designed to assess the safety, tolerability and pharmacokinetics of APL-102 delivered via an oral capsule."APL-102 is an internally discovered and developed tyrosine kinase inhibitor targeting multiple oncogenic drivers, and we are excited about advancing it for clinical testing to explore its potential for treating a number of solid tumors;" said Guo-Liang Yu, PhD, Co-Founder, Chairman and Chief Executive Officer. "APL-102 is the first of several novel assets planned for clinical development to further expand Apollomics' clinical pipeline in oncology."About APL-102APL-102 is an oral, small molecule multi kinase inhibitor (MTKi) targeting several key oncogenic drivers. APL-102 inhibits several receptor tyrosine kinases (RTKs), including: angiogenesis via vascular endothelial growth factor...

Read More

冠科美博(APOLLOMICS)APL-102 中国I期临床研究完成首例患者给药

Foster City, CA, Hangzhou and Shanghai, China, Aug 10, 2021 - (亚太商讯 via SEAPRWire.com) - 冠科美博( Apollomics Inc.),一家致力于发现和开发肿瘤靶向和免疫新药及其组合疗法的创新生物制药公司,今天宣布,APL-102已经成功完成首例患者给药。这是一项在晚期实体瘤患者中进行的 I期临床研究,旨在评估口服APL-102胶囊的安全性、耐受性和药代动力学特征。公司联合创始人、董事长兼首席执行官余国良博士说:“APL-102是我们自主研发发现和开发的一款抗肿瘤多靶点酪氨酸激酶抑制剂,我们很高兴能将其推进临床试验,以探索其治疗多种实体瘤上的潜力。冠科美博正在拓展抗肿瘤临床产品管线,APL-102是我们计划推进临床阶段的几个创新产品中的第一个。”关于APL-102APL-102是一种口服多激酶抑制剂(MTKi),针对几种关键的致癌驱动因子。APL-102抑制受体酪氨酸激酶(RTKs),包括:通过血管内皮生长因子受体(VEGFR)的血管生成;通过B-RAF和C-RAF的丝裂原活化蛋白激酶(MAPK)通路;集落刺激因子-1受体(CSF1R)。临床前研究显示其在肝癌、乳腺癌、结直肠癌、胃癌、食道癌和肺癌的患者来源的肿瘤移植小鼠模型(PDX)中表现出广泛且有效的抗肿瘤活性。APL-102 还显示出良好的临床前药代动力学 (PK) 和安全性特征,未观察到严重的脱靶活性。APL-102不仅有可能作为单一药物治疗患者,也具有和其他药物联用的巨大潜力。冠科美博拥有APL-102的全球权利。关于冠科美博(Apollomics Inc.)冠科美博( Apollomics Inc.)是一家创新型生物制药公司,致力于研发肿瘤靶向和免疫单药及其组合疗法。公司产品管线有多个处于不同开发阶段的项目,包括为恢复机体免疫系统识别能力和杀死癌细胞的新型人源化单克隆抗体和为针对失控的生长信号通路的靶向疗法。公司在中国杭州市、上海市和美国加州福斯特市均有运营实体。欲了解更多信息,请访问 www.apollomicsinc.com。冠科美博联系方式:投资人联系人:Wilson W. Cheung首席财务官电话:(650) 209-4436Email:wcheung@apollomicsinc.com公司联系人:张立平高级市场总监电话:(86) 0571-83521933Email:liping.zhang@apollomicsinc.com中国媒体联系:博达浩华国际财经传讯集团冯嘉莉总经理电话:(852) 3150 6763Email:kelly.fung@pordahavas.com冯静仪副总裁电话:(852) 3150 6773Email:phoenix.fung@pordahavas.com Copyrig...

Read More

Apollomics, Inc. Doses First Patient in A Phase I Clinical Trial of APL-102

Foster City, CA, Hangzhou and Shanghai, China, Aug 10, 2021 - (ACN Newswire via SEAPRWire.com) - Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination oncology therapies, today announced the successful dosing of the first patient in a Phase I clinical study of APL-102 in patients with advanced solid tumors. The Phase I trial is designed to assess the safety, tolerability and pharmacokinetics of APL-102 delivered via an oral capsule."APL-102 is an internally discovered and developed tyrosine kinase inhibitor targeting multiple oncogenic drivers, and we are excited about advancing it for clinical testing to explore its potential for treating a number of solid tumors;" said Guo-Liang Yu, PhD, Co-Founder, Chairman and Chief Executive Officer. "APL-102 is the first of several novel assets planned for clinical development to further expand Apollomics' clinical pipeline in oncology."About APL-102APL-102 is an oral, small molecule multi kinase inhibitor (MTKi) targeting several key oncogenic drivers. APL-102 inhibits several receptor tyrosine kinases (RTKs), including: angiogenesis via vascular endothelial growth factor...

Read More

Hawker centres, coffee shops welcome back diners even though only two can eat together

SINGAPORE - After many weeks of providing only takeaways, hawker centres and coffee shops welcomed back diners on Tuesday (Aug 10) as couples and families with children headed out for breakfast. At Bukit Panjang Hawker Centre and Market as well as 505 Jurong West Market and Food Centre, a steady stream of customers was seen at some stalls. Most of the available seats at the markets were taken even as diners stuck to groups of two. Safe distancing ambassadors were out in full force to ensure diners check in with their TraceTogether app or token at the dedicated entry points of these hawker centres. On Tuesday, the ban on dining in, imposed since July 22, was lifted. Groups of up to five people are allowed to dine at restaurants and eateries if all the diners are fully vaccinated. The group size at hawker centres and coffee shops is capped at two people, regardless of vaccination status. The easing of restrictions comes as 70 per cent of Singapore's population - or more than 3.86 million - has been fully vaccinated as at Sunday. Engineering manager Steven Lim, 50, who was having breakfast with his wife and two-year-old daughter at 505 Jurong West Market and Food Centre, said: "It fee...

Read More

Quarantine for staff and patients of NKF dialysis centre with Covid-19 cluster

SINGAPORE - All front-line staff and some patients of the NKF Dialysis Centre (Sakyadhita) in Boon Keng have been placed on quarantine after it was announced on Monday (Aug 9) that there was a Covid-19 cluster linked to it. Nursing and operational staff as well as patients who had been at the centre at the same time as the confirmed cases have been quarantined. The patients will go to another dialysis centre, designated by the Health Ministry, to receive treatment during their quarantine period, said the National Kidney Foundation (NKF). In a statement on Tuesday, NKF said three of its patients had tested positive for Covid-19 and are hospitalised. All are in a stable condition and are not in the intensive care unit. NKF added that deep cleaning and disinfection of the dialysis centre was done on Saturday. It has activated and deployed its Covid-19 Emergency Response Team to the affected dialysis centre to ensure continuity of care and minimise disruption. NKF said it was working closely with the Health Ministry to monitor the situation and ensure that the necessary safety and precautionary measures are taken to curb further transmission. "Dialysis patients need to continue with th...

Non-profit organisation seeks to build connections between youth in Asean and China

SINGAPORE - It was her knowledge of Malay that helped Ms Lee Zi Xin, 26, land an internship in a venture capital firm in what some would consider an unlikely place - China. Having spent six years learning Malay as a third language in school as well as having done her master's degree in Mandarin, Ms Lee's strong bilingual ability allowed her to function as a channel between the firm and start-ups in Malaysia and Indonesia. Please subscribe or log in to continue reading the full article. Get unlimited access to all stories at $0.99/month Latest headlines and exclusive stories In-depth analyses and award-winning multimedia content Get access to all with our no-contract promotional package at only $0.99/month for the first 3 months* Subscribe now *Terms and conditions apply.

Read More

AHEAD to Support Decarbonization at Petroleum Refineries Through MCH Hydrogen Supply Chain from Brunei

TOKYO, Aug 10, 2021 - (JCN Newswire via SEAPRWire.com) - Chiyoda Corporation, Mitsubishi Corporation, Mitsui & Co., Ltd. and Nippon Yusen Kabushiki Kaisha (hereinafter "the partners") are pleased to announce that they have signed an agreement with ENEOS Corporation (ENEOS) to supply hydrogen produced in Brunei for use in the latter's refinery decarbonization trials. The hydrogen, which will be delivered via a saturated hydrocarbon called methylcyclohexane (MCH), will be supplied by the Advanced Hydrogen Energy Chain Association for Technology Development (AHEAD), an organization that was jointly established by the partners in July 2017.Hydrogenation plant in BruneiHydrogen has considerable potential as a clean energy. It emits no CO2 and can be used in power generation, mobility, and many other industries to play a key role in future efforts to decarbonize. Unfortunately, there are two rather significant technical hurdles that need to be cleared before a hydrogen society can be realized. One is developing a stable, large-scale, and long-distance supply network that is capable of linking suppliers and consumers in different parts of the world. The other is securing reliable, lon...

Read More

AMDL, a Subsidiary of China Biotech Services, is Exclusively Licensed to Distribute FDA Approved Lung & Colon Cancer Companion Diagnostic Assay in Several Asian Regions Including China

HONG KONG, Aug 10, 2021 - (ACN Newswire via SEAPRWire.com) - China Biotech Services Holdings Limited ("CH BIOTECH SER " or "Company", stock code: 8037.HK) is pleased to announce that Asia Molecular Diagnostic Laboratory ("AMDL"), a subsidiary of the Company, has been exclusively licensed by its shareholder Pillar Biosciences, Inc. ("Pillar") to distribute Pillar's FDA (U.S. Food and Drug Administration) approved oncoRevealTM Dx Lung and Colon Cancer Assay (the "Assay") in part of Asian countries including China (specifically in Guizhou, Sichuan, Liaoning, Hong Kong and Macau), all ASEAN countries & etc. (collectively, the "Regions").Pillar, an invested enterprise of CH BIOTECH SER, received the Premarket Approval ("PMA") on its oncoReveal(TM) Dx Lung and Colon Cancer Assay from FDA on July 30th, 2021. CH BIOTECH SER currently holds a seat on the board of Pillar.The Assay is a NGS tissue-based companion diagnostic test for qualitative detection of somatic mutations in DNA derived from non-small cell lung cancer (NSCLC) and colorectal cancer (CRC). The grant of oncoReveal(TM) Dx Lung and Colon Cancer Assay's PMA was based on clinically validated data and allows for the test to be...

Read More

Seedo Subsidiary Awarded Grant from Israeli innovation Authority

Tel Aviv, Israel, Aug 10, 2021 - (ACN Newswire via SEAPRWire.com) - Seedo Corp. (saffron-tech.ag) (OTC: SEDO) subsidiary has been awarded a $1,000,000 (One Million) grant from the Israeli Innovation Authority. The new grant will allow the AgTech company to accelerate its R&D program building on its groundbreaking development of the protocols for growing saffron using vertical farming technology. The funds will be allocated to enable the company expand its facilities, allowing it to grow more saffron for commercial use. This will bring the company closer than ever to achieving its mission to revolutionize the billion-dollar saffron market by bringing a large-scale supply of the spice to the market. The Israel Innovation Authority is an independent publicly funded agency created to provide funding platforms aimed at effectively addressing innovation ecosystems. This grant demonstrates the Israel Innovation Authority recognition of the innovation and potential of the company's technology and solutions. "We are very proud to receive this funding from the Israeli Innovation Authority," says David Freidenberg, CEO, Seedo Corp. "In this new era of agriculture that incorporates innovat...

HSBC lures US$9.3b in private banking inflows in Asia

HONG KONG (BLOOMBERG) - HSBC Holdings attracted US$9.3 billion (S$12.6 billion) in net new money for its private banking business in Asia during the first half, with client assets rising 25 per cent from a year ago. Its Asia wealth balances - which include its Premier & Jade deposits and global private banking client assets - reached a record of about US$810 billion, accounting for nearly half of the total globally, it said in a statement. The London-based bank is pinning its future on Asia, and has outlined ambitious plans to expand in wealth management, particularly in China. It is shifting billions of dollars to Asia and plans to hire more than 5,000 new wealth planners to grow its business over the next three to five years. The bank continued to add Asian wealth front-line staff in the first half, with around 600 full-time employees hired, it said in the statement. This included 350 personal wealth planners for HSBC Pinnacle, the bank's mobile personal wealth planning service in mainland China. HSBC joins rivals, including Credit Suisse Group, Citigroup and Nomura Holdings, in a battle to manage growing wealth in the region. Citigroup attracted close to US$15 billion in net new...

United States Federal Reserve officials say tapering is near, advancing discussion on rate hike

NEW YORK (REUTERS) - Two Federal Reserve officials said on Monday that the United States economy is growing rapidly and that while the labour market still has room for improvement, inflation is already at a level that could satisfy one leg of a key test for the beginning of interest rate hikes. Atlanta Federal Reserve Bank president Raphael Bostic said he is eyeing the fourth quarter for the start of a bond purchase taper but is open to an even earlier start if the job market keeps up its recent torrid pace of improvement. Moreover, he and Richmond Fed president Tom Barkin both said they believe inflation has already achieved the Fed's 2 per cent threshold, according to their separate assessments. That is one of two requirements to be met before rate hikes can be considered. Their remarks are a sign that as Fed officials hold discussions about how and when to taper their asset purchases, they are also getting more detailed in their debate about what it will take to satisfy the Fed's inflation target under the new framework. Dr Bostic, who has already pencilled in late next year for the start of rate hikes, pointed to the five-year annual average for the core personal consumption ex...

Read More

Morning Briefing: Top stories from The Straits Times on Aug 10

Good morning! Here are our top stories to kick-start your Tuesday, Aug 10. Recovered individuals still need pre-event Covid-19 test exemption from a clinic to dine in: MOH Singapore kicks off differentiated community measures based on vaccination status from Tuesday. READ MORE HERE S'pore residents can walk in for Covid-19 jabs at 37 vaccination centres from Aug 10 without appointment This applies to all Singaporeans, permanent residents and long-term pass holders. READ MORE HERE Covid-19 cluster at an NKF dialysis centre; 10 patients in ICU The last time the number of ICU cases reached the double digits was in May 2020. READ MORE HERE More on this topic Related Story ST newsletters: Get alerts on the latest news Singapore marks 56th birthday with 600-strong ceremonial parade at Marina Bay Monday's parade takes place as 70 per cent of the population is fully vaccinated, and a day before some restrictions are eased. READ MORE HERE Acting now will mean a safer future, leaders and experts say in reaction to IPCC climate report Report predicts more dangerous future, especially for the poorest and most vulnerable. READ MORE HERE Malaysian singer Siti Sarah dies of Covid-19 three days af...

AMC posts upbeat results as people return to theatres

BENGALURU (REUTERS) - Cinema operator AMC Entertainment beat second-quarter revenue estimates on Monday, lifted by the return of movie-goers to its theaters after a year of closures and restrictions, sending its shares up 4 per cent in extended trading. F9: The Fast Saga - the latest instalment of the Fast and Furious series - and Godzilla Vs Kong gave AMC much-needed relief from the blows it has taken from the pandemic over the past year due to theatre closures. "In short, AMC crushed it in Q2," chief executive Adam Aron said on a conference call. Aron added that AMC will have the technology in place to receive payment in Bitcoin by the end of the year as payment for movie tickets and concessions. Nearly all of AMC's theatres reopened during the quarter as more people got vaccinated and pandemic-related curbs were eased. Mr Aron said that US ticket revenue so far in the third quarter was on track to reach 45 per cent of the same quarter in 2019 and was up from 29 per cent for the second quarter. "That trend line is pointing up. We certainly have a way to go but the progress is clear." Ticket sales at the world's largest theatre chain are still far off what it was raking in two yea...

Temasek-backed UpGrad scores US$185m to join India’s unicorns

BENGALURU (BLOOMBERG) - UpGrad has raised US$185 million (S$251 million) from Temasek and other investors over a span of a few months this year, garnering a valuation of US$1.2 billion that ranks it as India's third-largest edtech unicorn. The higher education start-up doubled in valuation within 60 days of its first financing round of US$120 million from Temasek, later adding another US$65 million from latest backers International Finance Corporation and India's IIFL. In a release, the start-up referenced but did not confirm Indian media reports it is now in discussions to raise US$400 million at a US$4 billion valuation. India's education start-ups are riding an upswell of demand during the Covid-19 pandemic that has buoyed leader Byju's and smaller rivals like Unacademy and UpGrad. Dozens of start-ups have closed funding rounds from global investors betting on Indian-built start-ups going international. "We are very focused on our path to being in the top 3-5 companies globally in EdTech and serve the one billion workforce across the age group of 18 to 60 years," UpGrad's chairman and co-founder Ronnie Screwvala said in a statement. The start-up will announce more acquisitions s...

Read More

Singapore needs more teams to vaccinate those homebound; existing medical teams stepping up

SINGAPORE - Lugging a cooler chest containing Covid-19 vaccines and a 15kg suitcase filled with medical equipment, resuscitation tools and an oxygen canister, Dr Nathaniel Ng and a nurse headed to a Housing Board flat in Hougang to vaccinate a senior citizen. After thoroughly checking that the woman was eligible for vaccination, and recording her vitals, the nurse administered the injection. They then observed the bedbound senior for 30 minutes. After confirming that she had no allergic or anaphylactic reactions, and therefore no need for their standby resuscitation equipment or medicines, they bid farewell and moved to the next location. They had at least 10 more homes to visit. The daily workload has doubled in recent weeks for Dr Ng and the dozen other home vaccination teams conducting at-home jabs. The scheme caters to immobile seniors who are not able to make their own way to vaccination centres. When it started in June, each home vaccination team visited six to eight households a day. Since a month ago, they have had to inoculate up to 14 seniors a day, working shifts that last between 10 and 12 hours, said Dr Ng, who is medical director of home care service Jaga-Me. Last Fri...

Read More

Building a thriving tech ecosystem in Singapore

SINGAPORE - The start-up scene here has much to show for in 2021, producing an impressive string of built-in-Singapore unicorns, which are private companies now valued at more than US$1 billion (S$1.4 billion). Despite the economic headwinds induced by the pandemic, technology companies like PatSnap, Carro, Nium and others have achieved remarkable growth, carving out dominant positions regionally and even globally - in areas such as e-commerce, intellectual property, fintech, the biosciences and property tech. Following in the footsteps of tech giants Grab and Sea, local start-ups are now making confident strides along a well-beaten path from seed and Series A funding rounds to a high-profile public listing. Collectively, the tech community - what some have called Singapore Tech Inc - is flying the national colours high. But how has Singapore done it - and how should the country ensure ongoing success on this front? What the tech community needs Singapore may not have a large marketplace allowing start-ups to scale quickly in a single jurisdiction - an important enabler for tech companies that make it big in the United States, China, India and the Euro zone. But an awareness of its...

Read More

VC Holdings Expects a Turnaround in 1H 2021

HONG KONG, Aug 9, 2021 - (ACN Newswire via SEAPRWire.com) - Value Convergence Holdings Limited ("VC Holdings", together with its subsidiaries, the "Group"; Stock Code: 0821.HK) announced that, based on its preliminary assessment of the unaudited consolidated financial statements of the Group for the six months ended 30 June 2021 ("Reporting Period"), the Group is expected to turnaround and record an unaudited consolidated profit attributable to owners of the Company of approximately HK$100 million for the Reporting Period as compared to that of a loss of approximately HK$55 million for the same period last year. The turnaround is mainly attributable to the increase in revenue of approximately HK$10 million, mainly from interest income generated from margin financing and money lending businesses. Meanwhile, a net realised and unrealised gain in financial assets at fair value through profit or loss of approximately HK$79 million was recorded, as compared with the net realised and unrealised loss of approximately HK$22 million for the same period last year. Last but not least, reversal of impairment loss on receivable of approximately HK$29 million was recorded in the Reporting Period...